What is Wolfe Research's price target for ABT?

Wolfe Research's latest stated price target for Abbott Laboratories (ABT) is $130, from its action on Aug 13, 2026.

What is Wolfe Research's rating on ABT?

Wolfe Research rates ABT Outperform, a bullish rating, as of Aug 13, 2026.

When did Wolfe Research last change its view on ABT?

On Aug 13, 2026, Wolfe Research upgrades to Outperform from Peer Perform, price target $130.

Wolfe Research ABT price target and rating history

Wolfe Research rates Abbott Laboratories (ABT) Outperform with a $130 price target, as of its latest action on Aug 13, 2026. It has published 4 rating actions on ABT since July 2022, including 2 upgrades and 0 downgrades. Across 5 firms with a ABT price target in the last 12 months, the median target is $121. Wolfe Research's $130 is 7% above that.

Current rating: Outperform
Price target: $130
Median target, all firms: $121
Actions on ABT: 4

Wolfe Research price target on ABT

Wolfe Research price target on ABT, each point a stated target, July 2022 to August 2026.

Every Wolfe Research rating on ABT

Aug 13, 2026
UpgradeWolfe Research upgrades to Outperform from Peer Perform, price target $130
Jul 21, 2023
UpgradeWolfe Research upgrades to Peer Perform from Underperform
Apr 20, 2023
ReiterateWolfe Research cuts its price target to $103 from $107, keeps Underperform
Jul 6, 2022
InitiateWolfe Research starts coverage at Underperform, price target $95

How other firms rate ABT

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
Argus Research	Hold		Oct 27, 2026
Barclays	Overweight	$120	Oct 7, 2026
Rothschild & Co Redburn	Buy	$127	Oct 2, 2026
Wolfe Research	Outperform	$130	Aug 13, 2026
Robert W. Baird	Outperform	$121	Jul 1, 2026
Daiwa	Neutral	$92	Apr 22, 2026

Questions about Wolfe Research and ABT

What is Wolfe Research's price target for ABT?: Wolfe Research's latest stated price target for Abbott Laboratories (ABT) is $130, from its action on Aug 13, 2026.
What is Wolfe Research's rating on ABT?: Wolfe Research rates ABT Outperform, a bullish rating, as of Aug 13, 2026.
When did Wolfe Research last change its view on ABT?: On Aug 13, 2026, Wolfe Research upgrades to Outperform from Peer Perform, price target $130.
How does Wolfe Research's ABT target compare with other analysts?: Across 5 firms with a ABT price target in the last 12 months, the median target is $121. Wolfe Research's $130 is 7% above that.

More ABT rating histories

All Wolfe Research ratings ABT news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.